Schulman Associates IRB Establishes Itself in Canada


Cincinnati, OH-Oct. 27, 2009

Schulman Associates IRB (Schulman) has expanded its IRB services into Canada with an office in Toronto because of requests from clients, according to the company. The Schulman Canadian Board’s first official meeting is scheduled for this week.

For North American studies which are conducted in both the U.S. and Canada, Canadian and U.S. Board members will review the research together in order to maintain consistency.

“Our clients have asked us to provide review services in Canada. Now that our Canadian IRB is operational, Schulman can provide the for Canadian research as it has provided in the U.S. for the past 26 years,” said Schulman’s CEO, John Isidor.

Schulman provides clients conducting Canadian studies with access to its WebPortal 2.0 service. WebPortal 2.0 interfaces directly with Schulman’s internal system to provide Sponsors and CROs with real-time updates on review status and timelines.

Early next year, Schulman will launch updated electronic tools to provide clients with greater access to critical review information. Schulman’s existing submission forms have been revised to comply with Canadian regulations and terminology. The revisions are minor and the forms will remain familiar to Schulman clients who have used them for U.S. studies.

French-speaking support is available for Canadian studies. Schulman’s U.S. institutional review board is fully accredited by the Association for Accreditation of Human Research Protection Programs (AAHRPP).

For more information on Schulman call Client Services at 513-761-4100 or visit

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Applied Clinical Trials and LabConnect
Related Content
© 2024 MJH Life Sciences

All rights reserved.